⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management

Official Title: Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management

Study ID: NCT02335398

Conditions

Pain, Chronic

Interventions

Methadone

Study Description

Brief Summary: Methadone is a synthetic mu opioid agonist that has been proved as clinically effective in pain management. However, methadone usage for pain control in Thailand has been limited because physicians are not familiar with its dosing and concern about the risk of drug accumulation and cardiac arrhythmia. Therefore, this prospective study was conducted to evaluate the efficacy and safety of a methadone protocol in Thai patients with severe chronic noncancer and cancer pain.

Detailed Description: Chronic pain is defined as pain that persists beyond normal tissue healing time, which is assumed for 3 months by the IASP. The symptoms include either continuous or intermittent pain, that could be caused by tumor or other multiple etiologies. The consequence of uncontrolled chronic pain presents not only physiologic symptoms but also psychiatric disorders leading to severely impact daily living. In Thailand, the use of methadone for pain management has been limited because physicians are not familiar with its dosing and concern about the risk of drug accumulation and cardiac arrhythmia. Therefore, the aim of this study is to evaluate the efficacy and safety of a protocol of methadone dosing in outpatients with severe chronic pain. Thirty four chronic pain patients will be included to initiate methadone use following the protocol. Pain scores, pain interferences scores, neuropathic pain score, severity of adverse effects, and QTc intervals will be assessed at baseline, and two, four, eight, and twelve weeks after starting methadone. The approved protocol of methadone therapy obtained from this study could be clinically utilized by physicians for severe chronic pain management.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Siriraj Hospital, Bangkoknoi, Bangkok, Thailand

Contact Details

Name: Chuthamanee Suthisisang, Ph.D.

Affiliation: Thailand: Faculty of Pharmacy, Mahidol University

Role: STUDY_CHAIR

Name: Phutsadee Pudchakan, Bsc.Pharm

Affiliation: Thailand: Faculty of Pharmacy, Mahidol University

Role: PRINCIPAL_INVESTIGATOR

Name: Krittika Tanyasaensook, Ph.D.

Affiliation: Thailand: Faculty of Pharmacy, Mahidol University

Role: STUDY_DIRECTOR

Name: Pongparadee Chaudakshetrin, M.D.

Affiliation: Thailand: Faculty of Medicine Siriraj Hospital

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: